Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00069407 · ClinicalTrials.gov registry record · NA

Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression

A NA study of Depression, sponsored by University of Medicine and Dentistry of New Jersey.

Completed
Registry status
NA
Development phase
230
Enrollment target
4
Study locations

NCT00069407: Completed NA study of Depression, sponsored by University of Medicine and Dentistry of New Jersey.

NCT00069407 is a NA study of Depression that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 230 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00069407, a NA study of Depression, has completed, sponsored by University of Medicine and Dentistry of New Jersey.

COMPLETED
Registry status
NA
Development phase
230 participants
Enrollment target
4
Study locations

Study Summary

This study will compare the antidepressant benefits and cognitive side effects of three different types of electroconvulsive therapy (ECT) in people with unipolar or bipolar depression.

Primary Outcome

Depression symptom rating

Conditions Studied

Interventions

  • PROCEDURE Electroconvulsive Therapy

Study Locations (4)

Minnesota

  • Mayo Clinic - Rochester

New Jersey

  • UMDNJ - Newark

New York

  • Northshore/Long Island Jewish Hillside Hospital - Glen Oaks

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2003-02
Est. Completion 2006-12
Phase NA

What the finished NCT00069407 record still lists

NCT00069407 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Electroconvulsive Therapy is the first listed.

NCT00069407 reports a single indexed study location in Minnesota, New Jersey, New York.

Frequently Asked Questions

What is clinical trial NCT00069407 about?

NCT00069407 is a clinical study titled "Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression". This study will compare the antidepressant benefits and cognitive side effects of three different types of electroconvulsive therapy (ECT) in people with unipolar or bipolar depression.

What is the current status of trial NCT00069407?

This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2003-02. Estimated completion is 2006-12.

What conditions does trial NCT00069407 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00069407?

The interventions under investigation include: Electroconvulsive Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT00069407?

This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00069407 being conducted?

This trial has 4 study locations across Minnesota, New Jersey, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00069407's enrollment target sits among peer trials

230 190th of 679 higher than 489 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00069407, the US trial registry maintained by the National Library of Medicine. NCT00069407 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.